DNTH
Dianthus Therapeutics Inc.
87.80$
-0.8%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | |
| – | +6,166.7% | +132.7% | +110.6% | +7.3% | +2.1% | -92.7% | +141.5% | +16.1% | +3.9% | |
| – | +241.2% | +373.8% | -6.6% | -0.6% | -99.4% | +2,309.5% | +91.0% | +344.6% | +76.8% | |
| – | – | – | – | – | – | +1,347.6% | – | – | – | |
| – | -17.4% | +202.3% | +121.7% | -113.4% | – | – | – | -107.2% | – | |
| – | +1,482.0% | +248.9% | -60.1% | -86.9% | +216.0% | -89.0% | -20.9% | -4.5% | +102.9% | |
| – | +1,482.0% | +4,070.2% | – | -794.2% | – | -237.7% | – | -1,516.1% | -57.2% | |
| – | +99.1% | -58.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +567.4% | +98.8% | -56.2% | +8.7% | +32.3% | +7.9% | +38.2% | +91.4% | +9.6% | |
| – | +1,063.1% | -85.6% | -0.8% | -202.9% | – | -89.4% | +1,402.1% | -193.5% | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.